|
Aurobindo Pharma Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
91749.23 Cr.
|
P/BV
|
2.42
|
Book Value (Rs.)
|
652.39
|
|
52 Week High/Low (Rs.)
|
1637/1016
|
FV/ML
|
1/1
|
P/E(X)
|
26.18
|
|
Bookclosure
|
17/04/2026
|
EPS (Rs.)
|
60.34
|
Div Yield (%)
|
0.25
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 17356.01 | 16028.73 | 16274.27 | 15103.86 | 15060.52 |
| Other Operating Income | 143.23 | 125.11 | 86.37 | 259.23 | -128.59 |
| Total Income From Operations | 17499.24 | 16153.84 | 16360.64 | 15363.09 | 14931.93 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 5260.23 | 5044.96 | 5528.25 | 5208.51 | 5310.40 |
| Purchase of Traded Goods | 1824.13 | 1653.85 | 1460.07 | 1427.04 | 1561.70 |
| Increase/Decrease in Stocks | -174.08 | -120.73 | -245.03 | -352.60 | -660.65 |
| Employees Cost | 2684.04 | 2506.13 | 2294.19 | 2181.43 | 2016.00 |
| Depreciation | 943.30 | 834.89 | 862.96 | 786.46 | 777.60 |
| Other Expenses | 4378.80 | 3788.11 | 3953.26 | 3713.00 | 3416.08 |
| Total Expenses | 14916.42 | 13707.21 | 13853.70 | 12963.84 | 12421.13 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 2582.82 | 2446.63 | 2506.94 | 2399.25 | 2510.80 |
| Other Income | 304.68 | 225.50 | 292.10 | 356.93 | 283.86 |
| P/L Before Interest, Excpt. Items & Tax | 2887.50 | 2672.13 | 2799.04 | 2756.18 | 2794.66 |
| Interest | 190.98 | 192.99 | 233.50 | 223.74 | 164.98 |
| P/L Before Exceptional Items & Tax | 2696.52 | 2479.14 | 2565.54 | 2532.44 | 2629.68 |
| Exceptional Items | -65.33 | 0.00 | 0.00 | 0.00 | -122.11 |
| P/L Before Tax | 2631.19 | 2479.14 | 2565.54 | 2532.44 | 2507.57 |
| Tax | 798.49 | 810.39 | 786.54 | 796.18 | 645.00 |
| P/L After Tax from Ordinary Activities | 1832.70 | 1668.75 | 1779.00 | 1736.26 | 1862.57 |
| Net Profit/Loss For the Period | 1832.70 | 1668.75 | 1779.00 | 1736.26 | 1862.57 |
| Minority Interest | 0.90 | 0.87 | 0.88 | 1.43 | -2.28 |
| Share Of P/L Of Associates | -2.06 | 3.58 | -30.60 | -1.09 | -15.25 |
| Net P/L After Minority Interest & Share Of Associates | 2059.27 | 1673.20 | 1749.28 | 1736.60 | 1845.04 |
| | | | | | |
| Equity Share Capital | 58.08 | 58.08 | 58.08 | 58.08 | 58.59 |
| Reserves And Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 29784.21 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 31.55 | 28.81 | 30.63 | 29.69 | 31.79 |
| Diluted EPS (Rs.) | 31.55 | 28.81 | 30.63 | 29.69 | 31.79 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 31.55 | 28.81 | 30.63 | 29.69 | 31.79 |
| Diluted EPS (Rs.) | 35.46 | 28.81 | 30.12 | 29.69 | 31.49 |
| | | | | | |
| PBITOE Margin (%) | 14.75 | 15.14 | 15.32 | 15.61 | 16.81 |
| PBTE Margin (%) | 15.40 | 15.34 | 15.68 | 16.48 | 17.61 |
| PBT Margin (%) | 15.03 | 15.34 | 15.68 | 16.48 | 16.79 |
| PAT Margin (%) | 10.47 | 10.33 | 10.87 | 11.30 | 12.47 |
| PAT After MI And SOA Margin (%) | 11.76 | 10.35 | 10.69 | 11.30 | 12.35 |
